{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:33Z","timestamp":1792787793522,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771589"],"award-info":[{"award-number":["81771589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Project of Tianjin Health Care Professionals","award":["16KG166"],"award-info":[{"award-number":["16KG166"]}]},{"name":"the Program of Tianjin Science and Technology Plan","award":["18ZXDBSY00170"],"award-info":[{"award-number":["18ZXDBSY00170"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To analyze the clinical characteristics of Mycoplasma pneumoniae pneumonia with hypoxia in children, and identify the associated risk factors of hypoxia in MPP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective case-control study was performed on 345 children with Mycoplasma pneumoniae pneumonia (MPP) admitted to our hospital wards from January 2017 to June 2019. They were divided into three groups, namely MPP with hypoxia, refractory Mycoplasma pneumoniae pneumonia (RMPP), and general Mycoplasma pneumoniae pneumonia (GMPP). The clinical features, laboratory findings, imaging, and management were collected and compared in the three groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The MPP with hypoxia patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200969) had longer disease duration, a higher extra-pulmonary complications rate, and more severe radiological abnormalities (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). They also needed more complicated treatments (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Meanwhile, the levels of white blood cell count (WBC), C-reactive protein (CRP), lactic dehydrogenase (LDH), interleukin (IL)-6, ferritin, D-dimer, fibrinogen (FG), alanine aminotransferase (ALT) and the percentage of neutrophils in the MPP with hypoxia group were significantly higher than those in the RMPP group and the GMPP group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). In ROC curve analysis, the percentage of neutrophils, WBC, CRP, LDH, IL-6, ferritin, D-dimer, and ALT were contributed to identify the MPP with hypoxia patients. Multivariate logistic regression analysis revealed that ferritin&gt;\u2009174.15\u2009ng\/mL, IL-6\u2009&gt;\u200925.475\u2009pg\/ml, and pleural effusion were significantly associated with the incidence of hypoxia in MPP (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MPP with hypoxia patients\u2002presented\u2002more\u2002serious\u2002clinical\u2002manifestations. Ferritin&gt;\u2009174.15\u2009ng\/mL, IL-6\u2009&gt;\u200925.475\u2009pg\/ml and pleural effusion were related risk factors for hypoxia in MPP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05270-6","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T08:03:38Z","timestamp":1595405018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children"],"prefix":"10.1186","volume":"20","author":[{"given":"Yaoyao","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunquan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"issue":"5","key":"5270_CR1","doi-asserted-by":"publisher","first-page":"e96674","DOI":"10.1371\/journal.pone.0096674","volume":"9","author":"WK Liu","year":"2014","unstructured":"Liu WK, Liu Q, Chen DH, et al. Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study. PLoS One. 2014;9(5):e96674.","journal-title":"PLoS One"},{"issue":"9","key":"5270_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835\u201345.","journal-title":"N Engl J Med"},{"issue":"1","key":"5270_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/MOP.0b013e328341579c","volume":"23","author":"S Hawkins","year":"2011","unstructured":"Hawkins S, Rausch CM, McCanta AC. Constrictive pericarditis secondary to infection with Mycoplasma pneumoniae. Curr Opin Pediatr. 2011;23(1):126\u20139.","journal-title":"Curr Opin Pediatr"},{"key":"5270_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fmicb.2016.00800","volume":"7","author":"K Izumikawa","year":"2016","unstructured":"Izumikawa K. Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia. Front Microbiol. 2016;7:800.","journal-title":"Front Microbiol"},{"issue":"7","key":"5270_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.14740\/jocmr3421w","volume":"10","author":"B Bajantri","year":"2018","unstructured":"Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res. 2018;10(7):535\u201344.","journal-title":"J Clin Med Res"},{"issue":"19","key":"5270_CR6","doi-asserted-by":"publisher","first-page":"e3605","DOI":"10.1097\/MD.0000000000003605","volume":"95","author":"SC Lee","year":"2016","unstructured":"Lee SC, Youn YS, Rhim JW, Kang JH, Lee KY. Early serologic diagnosis of Mycoplasma pneumoniae pneumonia: an observational study on changes in titers of specific-IgM antibodies and cold agglutinins. Medicine (Baltimore). 2016;95(19):e3605.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"5270_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jiac.2013.09.009","volume":"20","author":"K Izumikawa","year":"2014","unstructured":"Izumikawa K, Izumikawa K, Takazono T, et al. Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature. J Infect Chemother. 2014;20(3):181\u20135.","journal-title":"J Infect Chemother"},{"issue":"1","key":"5270_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12879-018-3346-8","volume":"18","author":"Y Ding","year":"2018","unstructured":"Ding Y, Chu C, Li Y, et al. High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2018;18(1):439.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"5270_CR9","first-page":"745","volume":"51","author":"Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Association CM, Editorial Board, Chinese Journal of Pediatrics","year":"2013","unstructured":"Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Association CM, Editorial Board, Chinese Journal of Pediatrics. Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I). Zhonghua Er Ke Za Zhi. 2013;51(10):745\u201352.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"11","key":"5270_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00247-017-3891-0","volume":"47","author":"S Andronikou","year":"2017","unstructured":"Andronikou S, Goussard P, Sorantin E. Computed tomography in children with community-acquired pneumonia. Pediatr Radiol. 2017;47(11):1431\u201340.","journal-title":"Pediatr Radiol"},{"issue":"4","key":"5270_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2169\/internalmedicine.40.345","volume":"40","author":"Y Takiguchi","year":"2001","unstructured":"Takiguchi Y, Shikama N, Aotsuka N, Koseki H, Terano T, Hirai A. Fulminant Mycoplasma pneumoniae pneumonia. Intern Med. 2001;40(4):345\u20138.","journal-title":"Intern Med"},{"issue":"4","key":"5270_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jama.1967.03130170087013","volume":"202","author":"JC Maisel","year":"1967","unstructured":"Maisel JC, Babbitt LH, John TJ. Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung. JAMA. 1967;202(4):287\u201390.","journal-title":"JAMA"},{"issue":"3","key":"5270_CR13","first-page":"491","volume":"122","author":"RJ Koletsky","year":"1980","unstructured":"Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis. 1980;122(3):491\u20136.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"5270_CR14","first-page":"413","volume":"4","author":"VM Novelli","year":"1985","unstructured":"Novelli VM, Matthew DJ, Dinwiddie RD. Acute fulminant toxic encephalopathy associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis. 1985;4(4):413\u20135.","journal-title":"Pediatr Infect Dis"},{"issue":"3","key":"5270_CR15","first-page":"91","volume":"61","author":"J de Boer","year":"2003","unstructured":"de Boer J, Aerdts SJ, Groeneveld PH. Severe diffuse interstitial pneumonia due to Mycoplasma pneumoniae in a patient with respiratory insufficiency. Neth J Med. 2003;61(3):91\u20134.","journal-title":"Neth J Med"},{"issue":"3","key":"5270_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1590\/s1679-45082011rc1764","volume":"9","author":"JF Almeida","year":"2011","unstructured":"Almeida JF, Stape A, Troster EJ. Acute respiratory distress syndrome caused by mycoplasma pneumoniae in a child: the role of methylprednisolone and clarythromycin. Einstein (Sao Paulo). 2011;9(3):386\u20138.","journal-title":"Einstein (Sao Paulo)"},{"issue":"4","key":"5270_CR17","first-page":"305","volume":"47","author":"R Gupta","year":"2005","unstructured":"Gupta R, Gupta A, Goyal V, Guleria R, Kumar A. Mycoplasma pneumonia associated with rhabdomyolysis and the Guillain-Barre syndrome. Indian J Chest Dis Allied Sci. 2005;47(4):305\u20138.","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"Pt 12","key":"5270_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1099\/jmm.0.47119-0","volume":"56","author":"N Miyashita","year":"2007","unstructured":"Miyashita N, Obase Y, Ouchi K, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol. 2007;56(Pt 12):1625\u20139.","journal-title":"J Med Microbiol"},{"issue":"913","key":"5270_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/pmj.77.913.723","volume":"77","author":"CU Joo","year":"2001","unstructured":"Joo CU, Kim JS, Han YM. Mycoplasma pneumoniae induced popliteal artery thrombosis treated with urokinase. Postgrad Med J. 2001;77(913):723\u20134.","journal-title":"Postgrad Med J"},{"issue":"7","key":"5270_CR20","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/ppul.24327","volume":"54","author":"C Yan","year":"2019","unstructured":"Yan C, Xue G, Zhao H, et al. Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2019;54(7):1012\u201321.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"5270_CR21","doi-asserted-by":"publisher","first-page":"e0156465","DOI":"10.1371\/journal.pone.0156465","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children. PLoS One. 2016;11(5):e0156465.","journal-title":"PLoS One"},{"issue":"1","key":"5270_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12879-020-05017-3","volume":"20","author":"J Zhao","year":"2020","unstructured":"Zhao J, Li Y, Zhang W. The clinical significance of IL-6\u2009s and IL-27\u2009s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20(1):331.","journal-title":"BMC Infect Dis"},{"issue":"Pt 6","key":"5270_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1099\/jmm.0.007872-0","volume":"58","author":"H Sekine","year":"2009","unstructured":"Sekine H, Taguchi H, Watanabe H, et al. Immunological analysis and pathological examination of gnotobiotic mice monoassociated with Mycoplasma pneumoniae. J Med Microbiol. 2009;58(Pt 6):697\u2013705.","journal-title":"J Med Microbiol"},{"issue":"1","key":"5270_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0022-510X(99)00089-1","volume":"165","author":"T Takata","year":"1999","unstructured":"Takata T, Hirakawa M, Sakurai M, Kanazawa I. Fulminant form of acute disseminated encephalomyelitis: successful treatment with hypothermia. J Neurol Sci. 1999;165(1):94\u20137.","journal-title":"J Neurol Sci"},{"issue":"1","key":"5270_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00431-002-1057-y","volume":"162","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Asato Y, Kukita I, et al. A 7-year-old boy with mycoplasmal infection requiring extracorporeal membrane oxygenation. Eur J Pediatr. 2003;162(1):44\u20136.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"5270_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000049377","volume":"69","author":"R Mizukane","year":"2002","unstructured":"Mizukane R, Kadota Ji J, Yamaguchi T, et al. An elderly patient with hemophagocytic syndrome due to severe mycoplasma pneumonia with marked hypercytokinemia. Respiration. 2002;69(1):87\u201391.","journal-title":"Respiration"},{"key":"5270_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2342-9-7","volume":"9","author":"N Miyashita","year":"2009","unstructured":"Miyashita N, Sugiu T, Kawai Y, et al. Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging. 2009;9:7.","journal-title":"BMC Med Imaging"},{"issue":"10","key":"5270_CR28","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.21037\/jtd.2017.09.75","volume":"9","author":"YD Yin","year":"2017","unstructured":"Yin YD, Wang R, Zhuo C, et al. Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study. J Thorac Dis. 2017;9(10):3774\u201381.","journal-title":"J Thorac Dis"},{"issue":"2","key":"5270_CR29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","volume":"58","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother. 2014;58(2):1034\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5270_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jmii.2014.11.003","volume":"49","author":"KN Cheong","year":"2016","unstructured":"Cheong KN, Chiu SS, Chan BW, To KK, Chan EL, Ho PL. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure. J Microbiol Immunol Infect. 2016;49(1):127\u201330.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"5270_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/INF.0b013e318234597c","volume":"31","author":"YC Hsieh","year":"2012","unstructured":"Hsieh YC, Tsao KC, Huang CG, et al. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae. Pediatr Infect Dis J. 2012;31(2):208\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"5270_CR32","first-page":"407","volume":"17","author":"DC Lung","year":"2011","unstructured":"Lung DC, Chan YH, Kwong L, Que TL. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Hong Kong Med J. 2011;17(5):407\u20139.","journal-title":"Hong Kong Med J"},{"issue":"50","key":"5270_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009364","volume":"96","author":"L Wang","year":"2017","unstructured":"Wang L, Lu S, Feng Z, et al. The early examination of combined serum and imaging data under flexible fiberoptic bronchoscopy as a novel predictor for refractory Mycoplasma pneumoniae pneumonia diagnosis. Medicine (Baltimore). 2017;96(50):e9364.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"5270_CR34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/C3MT00347G","volume":"6","author":"DB Kell","year":"2014","unstructured":"Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748\u201373.","journal-title":"Metallomics"},{"issue":"1","key":"5270_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12931-019-1152-5","volume":"20","author":"YJ Choi","year":"2019","unstructured":"Choi YJ, Jeon JH, Oh JW. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study. Respir Res. 2019;20(1):193.","journal-title":"Respir Res"},{"issue":"10","key":"5270_CR36","first-page":"1001","volume":"16","author":"F Tian","year":"2014","unstructured":"Tian F, Han B, Duan M. Serum tumor necrosis factor-\u03b1, interleukin \u22126 and galctin-3 concentrations in children with Mycoplasma pneumoniae pneumonia. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(10):1001\u20134.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05270-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05270-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05270-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:10:54Z","timestamp":1626894654000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05270-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5270"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05270-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.22954\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22954\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22954\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were following the Ethics Committee of Tianjin Children\u2019s Hospital. This article does not contain any studies with animals performed by any of the authors. The data used in this study were anonymized before its use.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"534"}}